BCL2 and lymphoma: Similarly, the Eμ-BCL2 transgenic strain, which places human BCL2 under the control of the 5’ IGH enhancer Eμ, shows an expansion of B cells and plasma cells, associated with autoimmune kidney disease but without increased incidence of lymphoma (74).